MD1 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP2544a
Background:
MD1 may cooperate with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and cytokine production. This protein is important for efficient CD180 cell surface expression. MD1 is highly expressed in B-cells, monocytes and tonsil. In monocytes, it is down-regulated by the cell-wall fraction of Mycobacterium bovis.
Other Names:
Lymphocyte antigen 86, Ly-86, Protein MD-1, LY86, MD1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2544a was selected from the N-term region of human MD1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: LY86
Gene ID: 9450
Primary Accession: O95711
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
MD1 may cooperate with CD180 and TLR4 to mediate the innate immune response to bacterial lipopolysaccharide (LPS) and cytokine production. This protein is important for efficient CD180 cell surface expression. MD1 is highly expressed in B-cells, monocytes and tonsil. In monocytes, it is down-regulated by the cell-wall fraction of Mycobacterium bovis.
Other Names:
Lymphocyte antigen 86, Ly-86, Protein MD-1, LY86, MD1
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2544a was selected from the N-term region of human MD1. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: LY86
Gene ID: 9450
Primary Accession: O95711
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review